Lv41
800 积分 2024-06-05 加入
Rituximab for idiopathic membranous nephropathy
3个月前
已完结
Rituximab for idiopathic membranous nephropathy
3个月前
已完结
Rituximab for idiopathic membranous nephropathy
3个月前
已完结
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
3个月前
已完结
Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy
3个月前
已完结
New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
3个月前
已完结
Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease
3个月前
已完结
Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
3个月前
已完结
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
3个月前
已完结
皖公网安备34019202002308
